Merrimack Pharmaceuticals, Inc.
MACK
$0.02
Change (1 day)
$15.89
Year High
$11.53
Year Low
Categories
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
P/E ratio for Merrimack Pharmaceuticals, Inc. (MACK)
P/E ratio as of 2023: -162.36
According to Merrimack Pharmaceuticals, Inc.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -162.36. At the end of 2022 the company had a P/E ratio of -100.38.
P/E ratio history for Merrimack Pharmaceuticals, Inc. from 2009 to 2023
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2023 | -162.36 |
| 2022 | -100.38 |
| 2021 | -21.35 |
| 2020 | -30.45 |
| 2019 | -1.98 |
| 2018 | -1.00 |
| 2017 | 0.23 |
| 2016 | -2.65 |
| 2015 | -4.68 |
| 2014 | -11.15 |
| 2013 | -3.17 |
| 2012 | -3.82 |
| 2011 | -5.54 |
| 2010 | -1.08 |
| 2009 | -1.10 |